Technology

Many voices, one Ontario. Independent journalism for Toronto, the GTA and Ontario. Free, fair, and focused on the communities we serve.

A video provided by a group claiming to be Palestine Action Canada showing red paint being splattered on the entrance to GeoSpectrum Technologies Inc. on Whittington Drive in Peterborough in the early morning hours of October 12, 2026. (kawarthaNOW screenshot) Peterborough police are investigating vandalism at a local defence technology company as a hate/bias crime incident after red paint and writing were discovered on the company’s building during the long weekend.

We have become obsessed with the idea that screens are destroying human connection. The evidence seems to be everywhere. Each week headlines warn of teenagers addicted to phones, a loneliness epidemic and the dangers of AI. The release of The Social Reckoning leads us to ask, “How bad were those guys at Meta?” and then ultimately wonder, “How bad am I if I still use Instagram?” In our day-to-day, we observe workers eating lunch alone while scrolling and friends choosing online games over offline gatherings. But what if we are focusing on the wrong problem? The greatest threat to connection may not be technology itself. It may be our growing unwillingness to curiously, thoughtfully and openly communicate about the role technology plays in our lives. As a pediatrician, this issue often manifests in my clinic. Parents arrive with worries about their teens’ screen time. The parent will demand that their child “fess up” and reveal how many hours they waste on their phone every day. The atmosphere is immediately charged. The teen becomes defensive. The parent is frustrated. I often suggest that we start somewhere else.

Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months. Patients with geographic atrophy (GA) have had treatments that slow lesion growth but nothing that restores central vision once it is lost. That changed in July 2026, when Science Corporation received a CE mark for the PRIMA photovoltaic retinal implant, making it commercially available across 30 European countries. The US Food and Drug Administration (FDA) review is ongoing. The 12-month results of the pivotal PRIMAvera trial were published in the New England Journal of Medicine in October 2025. In that trial, 26 of 32 participants who reached 12 months (81.3%) had a clinically meaningful gain in prosthetic visual acuity. The same report recorded 26 serious adverse events (SAEs) in 19 participants, most occurring within the first 2 months after implantation. As retina specialists begin fielding patient questions about the device, longer-term safety data and clear patient-selection criteria have become the central questions. At the American Academy of Ophthalmology 2026 Annual Meeting, Ehsan Rahimy, MD, presented 36-month safety data from PRIMAvera.

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on TSMC (TSM), Manhattan Associates (MANH) and International Business Machines (IBM) with bullish sentiments. TSMC (TSM)Bank of America Securities analyst Haas Liu reiterated a Buy rating on TSMC today and set a price target of $3260.00. The company’s shares closed last Friday at $453.31. Liu has an average return of 22.7% when recommending TSMC. ;'>According to TipRanks.com, Liu is ranked #3103 out of 12533 analysts. Currently, the analyst consensus on TSMC is a Strong Buy with an average price target of $883.00, implying a 90.2% upside from current levels. In a report issued on October 6, Barclays also maintained a Buy rating on the stock with a $665.00 price target. See the top stocks recommended by analysts >>Manhattan Associates (MANH)Manhattan Associates received a Buy rating and a $250.00 price target from Morgan Stanley analyst Chris Quintero yesterday. The company’s shares closed last Friday at $204.89. According to TipRanks.com, Quintero is a 1-star analyst with an average return of -3.3% and a 35.4% success rate.

Why the open-closed AI debate is more complicated than it seemsOctober 13, 2026Sarah Rogers/MIT Technology Review | Getty Images MIT Technology Review Explains: Let our writers untangle the complex, messy world of science and technology to help you understand what’s coming next. You can read more from the series here. Late last month, Anthropic released a report arguing that the model GLM-5.3 poses a major cyberattack risk. The report’s core concern is that the powerful new model, released in August by the Chinese company Z.ai, is freely available for anyone to download and modify. Anthropic’s assertion is only the latest move in a long-running debate about whether frontier AI models should be made open, like GLM-5.3, or should stay locked behind the doors of the frontier labs.  These days, much of the debate about how to handle open models is playing out in public—and there’s a lot of money resting on its outcome.

Analysts fell to the sidelines weighing in on ScanSource (SCSC) and Fortinet (FTNT) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. ScanSource (SCSC)Barclays analyst Guy Hardwick maintained a Hold rating on ScanSource today and set a price target of $51.00. The company’s shares closed last Friday at $60.93. According to TipRanks.com, Hardwick is a 5-star analyst with an average return of 16.6% and a 73.1% success rate. Hardwick covers the Technology sector, focusing on stocks such as Teledyne Technologies, TD SYNNEX Corporation, and Manhattan Associates. ;'>Currently, the analyst consensus on ScanSource is a Hold with an average price target of $51.00. See the top stocks recommended by analysts >>Fortinet (FTNT)In a report released today, Saket Kalia from Barclays maintained a Hold rating on Fortinet, with a price target of $210.00. The company’s shares closed last Friday at $194.75. According to TipRanks.com, Kalia is a 5-star analyst with an average return of 17.3% and a 62.2% success rate.

Powered by the Consumer Technology Association (CTA)® What if the room you sleep in could tell you something is off before you feel it? James Kotecki talks with Sam Yang, CEO and co-founder of Xandar Kardian, about a baseball-sized radar sensor that reads heartbeat and breathing from your nightstand or wall, with no camera, no microphone and nothing to wear. Built for hospitals and nursing homes, Sam says it has flagged changes in people’s vitals days before something went wrong, and it’s now coming to consumers. Hear why he says radar can measure breathing instead of estimating it, how sensing like this could show up in appliances and phones and what’s coming at CES 2027.

Seafood News and InsightIntraFish supplies the breaking news and insight to inform better business decisions throughout the value chain, from the sea to the supermarket shelf. Our global team of experts are focused on the needs of industry professionals, delivering news at speed and explaining why it matters – unrivalled intelligence to help you thrive within a rapidly changing global industry.

In a report released today, Samik Chatterjee from J. P. Morgan maintained a Buy rating on Apple, with a price target of $340.00. Chatterjee covers the Technology sector, focusing on stocks such as Apple, Salesforce, and Akamai. According to TipRanks, Chatterjee has an average return of 57.8% and a 76.83% success rate on recommended stocks. In addition to J. P. Morgan, Apple also received a Buy from Evercore ISI’s Amit Daryanani in a report issued on October 9. However, on October 6, UBS maintained a Hold rating on Apple (NASDAQ: AAPL). Based on Apple’s latest earnings release for the quarter ending June 27, the company reported a quarterly revenue of $109.42 billion and a net profit of $29.79 billion. In comparison, last year the company earned a revenue of $94.04 billion and had a net profit of $23.43 billion